Factor Xa inhibitors: next-generation antithrombotic agents.
Pinto
Donald J P
DJ
Research and Development, Bristol-Myers Squibb Company, PO Box 5400, Princeton, New Jersey 08543, USA.
Smallheer
Joanne M
JM
Cheney
Daniel L
DL
Knabb
Robert M
RM
Wexler
Ruth R
RR
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D001682:Biological Availability; D002986:Clinical Trials as Topic; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D065427:Factor Xa Inhibitors; D006487:Hemostasis; D006801:Humans; D008958:Models, Molecular; D011487:Protein Conformation; D013329:Structure-Activity Relationship; D013927:Thrombosis / Q000097:blood / Q000517:prevention & control*
D000925:Anticoagulants; D065427:Factor Xa Inhibitors